Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Mallinckrodt
Cerilliant
Medtronic
Teva
Dow
Julphar
Express Scripts
Cipla

Generated: October 19, 2017

DrugPatentWatch Database Preview

INDERAL Drug Profile

« Back to Dashboard

Which patents cover Inderal, and what generic Inderal alternatives are available?

Inderal is a drug marketed by Wyeth Pharms Inc, Wyeth Ayerst, and Ani Pharms Inc. and is included in three NDAs.

The generic ingredient in INDERAL is propranolol hydrochloride. There are twenty-one drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the propranolol hydrochloride profile page.

Summary for Tradename: INDERAL

US Patents:0
Applicants:3
NDAs:3
Bulk Api Vendors: see list110
Clinical Trials: see list50
Patent Applications: see list2,850
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:INDERAL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
INDERAL
propranolol hydrochloride
TABLET;ORAL016418-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
INDERAL
propranolol hydrochloride
SUSPENSION;ORAL019536-001Dec 12, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
INDERAL
propranolol hydrochloride
TABLET;ORAL016418-009Oct 18, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
INDERAL LA
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018553-004Mar 18, 1987ABRXYesNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
INDERAL
propranolol hydrochloride
TABLET;ORAL016418-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
INDERAL
propranolol hydrochloride
TABLET;ORAL016418-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
INDERAL
propranolol hydrochloride
TABLET;ORAL016418-010Oct 18, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
INDERAL
propranolol hydrochloride
TABLET;ORAL016418-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
INDERAL LA
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018553-003Apr 19, 1983ABRXYesNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
INDERAL LA
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018553-001Apr 19, 1983ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: INDERAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst
INDERAL
propranolol hydrochloride
SUSPENSION;ORAL019536-001Dec 12, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Covington
Julphar
Merck
Fish and Richardson
Johnson and Johnson
McKinsey
Healthtrust
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot